Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles
Clinical trial NCT02269241 · COMPLETED
Trial details
- NCT number
- NCT02269241
- Sponsor
- Laboratories Leon Farma, S.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-09
- Primary completion
- 2017-10-04
- Enrollment
- 1552
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.